منبع: MarketBeat
خبرگزاری
سهام
اهمیت متوسط
Novo Nordisk A/S Q2 Earnings Call Highlights
Novo Nordisk A/S NYSE: NVO reported second-quarter adjusted sales growth of 7% at constant exchange rates, supported by GLP-1 volume growth across its obesity and diabetes franchises, while lower realized prices and manufacturing-related costs weighed on margins.
نمادهای مرتبط
1
N
NVO
NVO
منبع: MarketBeat
مشاهده منبع